Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARK EDWARD JONAS

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1144219957
CMS profile
324477
Location
CINCINNATI, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$2,423.45

128 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,403.63 127
Education $19.82 1

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 128 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MARK EDWARD JONAS

NPI 1144219957 · CMS profile ID 324477

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

CINCINNATI, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 128 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1144219957?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MARK EDWARD JONAS, NPI 1144219957, CMS profile ID 324477. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 128 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1144219957?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). MARK EDWARD JONAS, NPI 1144219957, CMS profile ID 324477. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 128 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1144219957?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
MARK EDWARD JONAS, NPI 1144219957, CMS profile ID 324477, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 128 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1144219957?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

128 matching records · $2,423.45 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 128 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 128.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $3.0607/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576407 CMS
ABBVIE INC. $3.5207/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576405 CMS
Merck Sharp & Dohme LLC $21.6907/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048378757 CMS
Janssen Biotech, Inc. $17.4807/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988317491 CMS
Janssen Biotech, Inc. $12.8507/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988317565 CMS
ABBVIE INC. $13.6706/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576399 CMS
ABBVIE INC. $2.8906/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576401 CMS
ABBVIE INC. $4.4306/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576403 CMS
ABBVIE INC. $11.5506/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576395 CMS
ABBVIE INC. $12.8806/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576397 CMS
ABBVIE INC. $3.7206/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576393 CMS
ABBVIE INC. $16.3706/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576389 CMS
ABBVIE INC. $11.8706/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576391 CMS
ABBVIE INC. $12.0006/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576387 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.7806/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057229575 CMS
ABBVIE INC. $14.3006/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576385 CMS
Janssen Biotech, Inc. $10.3506/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988317637 CMS
NESTLE HEALTHCARE NUTRITION INC. $15.5806/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012527223 CMS
ABBVIE INC. $16.6706/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576383 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.6205/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055420155 CMS
GENZYME CORPORATION $14.9105/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050492365 CMS
Gilead Sciences, Inc. $11.0905/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026064244 CMS
Evoke Pharma, Inc. $14.6305/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056624689 CMS
ABBVIE INC. $13.2305/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576381 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.0305/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057101867 CMS
Merck Sharp & Dohme LLC $17.6605/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048378507 CMS
Janssen Biotech, Inc. $12.3405/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988317667 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.3305/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057362627 CMS
Janssen Biotech, Inc. $22.8205/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988317591 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.3705/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055420151 CMS
Janssen Biotech, Inc. $1.1805/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988317647 CMS
Janssen Biotech, Inc. $5.5705/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988317657 CMS
Ferring Pharmaceuticals Inc. $25.4505/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044175167 CMS
NESTLE HEALTHCARE NUTRITION INC. $12.8004/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012463471 CMS
ABBVIE INC. $17.8704/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576379 CMS
NESTLE HEALTHCARE NUTRITION INC. $437.1504/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012466673 CMS
ABBVIE INC. $14.7304/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576377 CMS
Ironwood Pharmaceuticals, Inc $14.4504/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045520029 CMS
ABBVIE INC. $9.4504/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576375 CMS
ABBVIE INC. $18.7904/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576373 CMS
INTERCEPT PHARMACEUTICALS, INC. $17.7304/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053824439 CMS
ABBVIE INC. $1.6804/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576371 CMS
Janssen Biotech, Inc. $17.6004/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988317627 CMS
Merck Sharp & Dohme LLC $16.6604/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048750927 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.6504/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057086833 CMS
ABBVIE INC. $14.8503/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576369 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.1703/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055420147 CMS
INTERCEPT PHARMACEUTICALS, INC. $13.2503/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053824435 CMS
ABBVIE INC. $18.3803/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997576367 CMS
Ironwood Pharmaceuticals, Inc $16.8503/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045554275 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,234.10 82
PY2020 $412.48 27
PY2021 $1,109.39 89
PY2022 $1,378.15 111
PY2023 $2,423.45 128
PY2024 $909.22 70

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $17,795.59 8
PY2020 Principal investigator $56,999.65 28
PY2019 Principal investigator $53,741.92 15

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Allergan, Inc. $3,139.45 06/24/2021 Non-covered Recipient Entity
GCGA PHYSICIANS INC CONSULTANTS FOR CLINICAL RSRC
AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis No dispute reported 06/30/2026 789014571
Principal investigator 1 Allergan, Inc. $591.00 06/15/2021 Non-covered Recipient Entity
GCGA PHYSICIANS INC CONSULTANTS FOR CLINICAL RSRC
Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH) No dispute reported 06/30/2026 789014569
Principal investigator 1 Allergan, Inc. $1,654.94 05/01/2021 Non-covered Recipient Entity
GCGA PHYSICIANS INC CONSULTANTS FOR CLINICAL RSRC
AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis No dispute reported 06/30/2026 789014567
Principal investigator 1 Allergan, Inc. $1,316.30 04/09/2021 Non-covered Recipient Entity
GCGA PHYSICIANS INC CONSULTANTS FOR CLINICAL RSRC
Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH) No dispute reported 06/30/2026 789014565
Principal investigator 1 Allergan, Inc. $300.00 04/07/2021 Non-covered Recipient Entity
GCGA PHYSICIANS INC CONSULTANTS FOR CLINICAL RSRC
Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH) No dispute reported 06/30/2026 789014563
Principal investigator 1 Allergan, Inc. $4,047.00 03/17/2021 Non-covered Recipient Entity
GCGA PHYSICIANS INC CONSULTANTS FOR CLINICAL RSRC
AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis No dispute reported 06/30/2026 789014561
Principal investigator 1 Allergan, Inc. $935.75 02/19/2021 Non-covered Recipient Entity
GCGA PHYSICIANS INC CONSULTANTS FOR CLINICAL RSRC
Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH) No dispute reported 06/30/2026 789014559
Principal investigator 1 Allergan, Inc. $5,811.15 01/25/2021 Non-covered Recipient Entity
GCGA PHYSICIANS INC CONSULTANTS FOR CLINICAL RSRC
AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis No dispute reported 06/30/2026 789014557